Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
Alejandra del C. Alonso, Leah Cohen, Christopher Corbo, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

Inflammation in obesity, diabetes, and related disorders
Theresa V. Rohm, Daniel T. Meier, Jerrold M. Olefsky, et al.
Immunity (2022) Vol. 55, Iss. 1, pp. 31-55
Open Access | Times Cited: 1161
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 194
Role of tau protein in Alzheimer's disease: The prime pathological player
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 1599-1617
Closed Access | Times Cited: 181
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 153
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Y. Rajesh, Thirumala‐Devi Kanneganti
Cells (2022) Vol. 11, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 150
Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer’s Disease: Role of Glutathione and Metal Ions
Rimil Guha Roy, Pravat K. Mandal, Joseph C. Maroon
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 17, pp. 2944-2954
Open Access | Times Cited: 81
Cerebral consequences of environmental noise exposure
Omar Hahad, María Teresa Bayo Jiménez, Marin Kuntić, et al.
Environment International (2022) Vol. 165, pp. 107306-107306
Open Access | Times Cited: 78
Aggregation of Disordered Proteins Associated with Neurodegeneration
Phoebe S. Tsoi, My Diem Quan, Josephine C. Ferreon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3380-3380
Open Access | Times Cited: 56
Specific post-translational modifications of soluble tau protein distinguishes Alzheimer’s disease and primary tauopathies
Nathalie Kyalu Ngoie Zola, Clémence Balty, Sébastien Pyr dit Ruys, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Health position paper and redox perspectives - Disease burden by transportation noise
Mette Sørensen, Göran Pershagen, Jesse D. Thacher, et al.
Redox Biology (2023) Vol. 69, pp. 102995-102995
Open Access | Times Cited: 44
Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases
Anastasiia Bohush, Paweł Bieganowski, Anna Filipek
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 4976-4976
Open Access | Times Cited: 100
Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
Yamini Madav, Sarika Wairkar, Bala Prabhakar
Brain Research Bulletin (2019) Vol. 146, pp. 171-184
Closed Access | Times Cited: 90
MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
Wei Wei, Zhiyong Wang, Lina Ma, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 87
Contribution of astrocytes to neuropathology of neurodegenerative diseases
Çiğdem Acıoğlu, Lun Li, Stella Elkabes
Brain Research (2021) Vol. 1758, pp. 147291-147291
Closed Access | Times Cited: 80
Insights into Disease-Associated Tau Impact on Mitochondria
Leonora Szabo, Anne Eckert, Amandine Grimm
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6344-6344
Open Access | Times Cited: 72
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?
Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 26-41
Open Access | Times Cited: 72
Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies
Dunhui Li, Craig S. McIntosh, Frank Mastaglia, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 72
Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential
Diego Julián Vesga-Jiménez, Cynthia Martin, George E. Barreto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2577-2577
Open Access | Times Cited: 52
Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
Chongyun Wu, Luoman Yang, Shu Feng, et al.
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 49
How phosphorylation impacts intrinsically disordered proteins and their function
Estella A. Newcombe, Elise Delaforge, Rasmus Hartmann‐Petersen, et al.
Essays in Biochemistry (2022) Vol. 66, Iss. 7, pp. 901-913
Open Access | Times Cited: 49
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103487-103487
Open Access | Times Cited: 43
Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer’s Disease-Related Pathologies in Wild-Type Mice
Mona Abdelhamid, Chunyu Zhou, Cha‐Gyun Jung, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2543-2543
Open Access | Times Cited: 39
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 15
Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease
Joanna Batko, Katarzyna Antosz, Weronika Miśków, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3401-3401
Open Access | Times Cited: 11
Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction
Simone Giovannuzzi, Daniel Chavarria, Gustavo Provensi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 4170-4193
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top